Skip to content

Auricular Acupuncture for Mild Cognitive Impairment: A Randomized Controlled Trial

Auricular Acupuncture for Mild Cognitive Impairment: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026001362
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment

Interventions

Ear Acupoint Group:Ear acupoint
False Acupoint Group:prosthetic ear

Sponsors

Shuguang Hospital Affiliated to Shanghai University of TCM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic Criteria Refer to the diagnostic criteria for MCI in the 2018 edition of "Chinese Guidelines for the Diagnosis and Treatment of Dementia and Cognitive Disorders (Part 5): Diagnosis and Treatment of Mild Cognitive Impairment": (1) Cognitive impairment reported by the patient/informant or identified by the clinician. (2) Cognitive testing confirms impairment in one or more cognitive domains. (3) Mild impairment in instrumental activities of daily living, but still able to live independently. (4) Does not meet the criteria for dementia. 2. Inclusion Criteria (1) Meets the above diagnostic criteria; (2) Age range: 50-75 years old; (3) Patients who can understand the content of the scale and are willing to receive treatment; (4) Participants who are willing to provide informed consent for this study; (5) Have good compliance and are willing to suspend other treatments related to this disease during the treatment period. Those who meet the above criteria may be included in the study.

Exclusion criteria

Exclusion criteria: (1) Metabolic diseases, including anemia, thyroid dysfunction, and deficiencies in folate and vitamin B12, which may lead to cognitive decline; (2) Severe mental disorders, such as major depressive disorder, or a history of carbon monoxide poisoning; (3) Acute or severe life-threatening illnesses; (4) Severe visual, auditory, or language impairments that prevent completion of neuropsychological assessments; (5) Other conditions deemed inappropriate for participation in this study by the investigator. Patients meeting any of the above six criteria will be excluded from this study.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment;

Secondary

MeasureTime frame
Auditory Word Learning Test - Huashan Edition;Shape Connecting Lines Test;Boston Naming Test;Hamilton Depression Rating Scale;Hamilton Anxiety Rating Scale;Pittsburgh Sleep Quality Index (PSQI);The concentration of oxyhemoglobin in the frontal lobe of the brain;

Countries

China

Contacts

Public ContactCui Huashun

Shuguang Hospital Affiliated to Shanghai University of TCM

huashunchoi@126.com13816612789

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026